Sleep supplement shows promise for memory decline
NCT ID NCT06029894
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 28 times
Summary
This study tested whether a dietary supplement called citicoline could improve sleep and thinking in 100 older adults with mild cognitive impairment (MCI), a condition that can lead to Alzheimer's disease. Participants took citicoline or a placebo for several months. Researchers measured sleep quality, daytime sleepiness, and Alzheimer's-related markers in blood and spinal fluid. The goal was to see if citicoline could help with sleep problems and slow cognitive decline.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Emory University School of Nursing
Atlanta, Georgia, 30322, United States
-
Goizueta Alzheimer's Disease Research Center
Atlanta, Georgia, 30329, United States
Conditions
Explore the condition pages connected to this study.